Use of elsiglutide to treat gastrointestinal mucositis including chemotherapy-induced diarrhea

MA40623AUndetermined Publication Date: 2016-03-17HELSINN HEALTHCARE SA +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40623
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-09-10
Filing Date: 2015-09-02
Publication Date: 2016-03-17

Application Information

Patent Timeline

10 Sep 2014

Priority

02 Sep 2015

Application

MA40623

17 Mar 2016

Publication

MA40623A

IPC: A61K38/16; A61P35/00

CPC: A61K38/26; A61K38/16; A61P1/00; A61P1/12; A61P35/00; A61P39/00; A61P43/00; A61K39/3955

Inventors: CALCAGNILE Selma; GIORGINO Ruben

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to the use of elsiglutide to prevent or reduce the occurrence of gastrointestinal damage caused by chemotherapeutic agents, including gastrointestinal mucositis and chemotherapy-induced diarrhea (cid).

Need to check novelty before this filing date? Find Prior Art